YAHOO! Finance
Key Focus Area
Life Sciences
The Opportunity
Innovative treatment approaches that hold the promise to cure disease are oftentimes considered too risky and lack the necessary funding and resources. At the same time, the prevalence of autoimmune diseases and allergies are rising, and the five-year cancer survival rates are virtually unchanged from 20 years ago despite a four-decade war. In 2030, cancer is expected to surpass heart disease to become the leading cause of death in the United States.
Traditional funding mechanisms for scientific and medical research often consider innovative ideas and treatments too risky, and they face significant financial and organizational barriers. Promising new treatments can wither on the vine in pre-trial stages while the disease burden continues to grow. From our groundbreaking cancer immunotherapy institute to our efforts to uncover a cure for allergies, we aim to speed to market treatments with the potential to improve health outcomes, reduce healthcare costs, and save millions of lives.
Who We Work With
Featured Initiatives
The Parker Institute for Cancer Immunotherapy is an unprecedented collaboration of the world's leading cancer centers, all working together to cure cancer once and for all. The Institute brings together the world’s top scientists, clinicians, and industry partners to lead a smart, coordinated cancer immunotherapy research effort to take discoveries from bench to clinical trials to bedside faster.
The Sean N. Parker Center for Allergy Research at Stanford University is the first center of its kind, aiming to not only find better treatments for children and adults with allergies, but to discover underlying immune mechanisms against the disease and develop a lasting cure.
The Sean N. Parker Autoimmune Research Laboratory at UCSF is devoted to understanding autoimmunity and laying the groundwork for new treatments of diseases ranging from type 1 diabetes to multiple sclerosis to rheumatoid arthritis.
The Sean Parker Institute for the Voice researches the entire spectrum of voice disorders to inform world-class clinical care for patients.
Through a $5 million grant from The Parker Foundation, Stand Up To Cancer and the Cancer Research Institute formed the Immunotherapy Dream Team of researchers dedicated to the clinical development of immune-based therapies to fight cancer.
Beneficiaries
University of California San Francisco
Research at the Immunology Program at University of California San Francisco will expand the understanding of autoimmune disease mechanisms in order to develop new therapies to improve treatments and reduce costs.
Weill Cornell Medicine
Weill Cornell Medical College provides care to patients with voice disorders and supports research geared at improving our understanding of voice disorders and developing new therapies.
Cancer Research Institute
The Cancer Research Institute is the world's only nonprofit organization dedicated exclusively to harnessing the immune system's power to conquer all cancers.